does tirzepatide cause gallstones GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications Why Does Rapid Weight Loss

FARXIGA is not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive therapy for kidney disease

Protein shakes may be better tolerated than solid foods when nausea occurs, as they require minimal preparation and can be consumed slowly

This staged approach ensures that any weight changes or appetite shifts can be clearly attributed to semaglutide rather than ongoing thyroid adjustment, simplifying medical monitoring and dose titration

doi: 10.1210/clinem/dgac549 39 WildingJPHBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al

Funding This research was supported by University Technology Mara (UiTM) under grant number 600-IRMI/FRGS 5/3(273/2019)